| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 38.43M | 39.33M | 38.46M | 29.31M | 24.96M |
| Gross Profit | 14.12M | 22.42M | 17.69M | 13.42M | 10.40M |
| EBITDA | 4.21M | -2.15M | -5.78M | -16.95M | -18.92M |
| Net Income | 1.17M | -6.29M | -10.05M | -22.03M | -20.22M |
Balance Sheet | |||||
| Total Assets | 17.18M | 14.99M | 19.61M | 22.01M | 19.69M |
| Cash, Cash Equivalents and Short-Term Investments | 6.56M | 5.29M | 8.10M | 5.41M | 17.07M |
| Total Debt | 10.39M | 8.27M | 11.00M | 1.59M | 1.35M |
| Total Liabilities | 16.16M | 15.64M | 17.27M | 9.72M | 3.86M |
| Stockholders Equity | 1.02M | -645.00K | 2.33M | 12.29M | 15.82M |
Cash Flow | |||||
| Free Cash Flow | 4.85M | 347.00K | -8.67M | -24.38M | -10.10M |
| Operating Cash Flow | 4.92M | 353.00K | -6.34M | -22.03M | -8.65M |
| Investing Cash Flow | -2.29M | -1.65M | -2.24M | -2.34M | -2.42M |
| Financing Cash Flow | -428.87K | -332.00K | 9.32M | 5.90M | -611.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
52 Neutral | AU$49.50M | 24.60 | 250.55% | ― | -6.86% | 51.88% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | AU$34.68M | -4.21 | -52.26% | ― | -36.68% | 79.41% | |
45 Neutral | AU$34.49M | -3.13 | -1009.84% | ― | 25.98% | 22.10% | |
43 Neutral | AU$71.03M | -6.64 | -59.96% | ― | ― | ― | |
42 Neutral | AU$4.12M | -1.98 | 20.02% | ― | -9.90% | 34.07% |
Doctor Care Anywhere Group PLC has scheduled its 2026 Annual General Meeting for Tuesday, 28 April 2026, in line with ASX listing requirements and under the authority of its board and company secretary. The company is also directing investors to its interactive online hub and news alert service, reinforcing engagement with shareholders as it pursues a growth strategy built on digital telehealth, partnerships, and data-led healthcare delivery.
The AGM date announcement provides clarity for investors and other stakeholders on the company’s governance calendar and engagement opportunities. By highlighting its strategic focus on scaling its telehealth platform and deepening partnerships with insurers and corporates, Doctor Care Anywhere underlines its ambition to strengthen its position in the UK private telehealth market and drive sustained value creation.
The most recent analyst rating on (AU:DOC) stock is a Hold with a A$0.20 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.
Doctor Care Anywhere reported a strong turnaround for 2025, delivering its first positive earnings per share as revenue rose 6.5% to £38 million and underlying EBITDA climbed to £5.3 million, a 13.9% margin. Net profit reached £1.2 million, contribution margin improved to 43.5%, and cash generation of £2.2 million lifted year-end cash to £6.6 million, with management reaffirming medium-term ambitions to double revenue over three to five years and sustain a 15% EBITDA margin.
Operationally, the group broadened its platform by adding mental health practitioners and physiotherapists, which improved patient access and reduced cost to serve, while activated lives increased 7.9% to about 1.28 million. Overall consultation volumes fell 4% due to the prior closure of a secondary care pathway, but excluding that impact they were flat and returned to 3.4% growth in the second half, indicating strengthening demand from new products and clients and a firmer competitive footing in digital healthcare.
The most recent analyst rating on (AU:DOC) stock is a Hold with a A$0.16 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.
Doctor Care Anywhere reported renewed consultation growth in the second half of 2025, with volumes up 3.4% and consistently above 2024 levels since May, supported by a 7.9% year-on-year increase in activated lives to 1.3 million and a rise in repeat patients to 75% of consultations, indicating stronger engagement and loyalty despite seasonal quarter-on-quarter softness. The company delivered its third consecutive quarter of positive cash generation, with £1.1m net operating and investing cash inflow in Q4 and a strengthened cash balance of £6.6m, while advancing digital treatment pilots in musculoskeletal, mental health and dermatology, developing new propositions in corporate weight management and preventative health, and reaffirming medium-term guidance to double revenue over three to five years and target a 15% EBITDA margin, underscoring confidence in its growth trajectory and investment capacity.
The most recent analyst rating on (AU:DOC) stock is a Sell with a A$0.13 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.
Doctor Care Anywhere Group PLC has announced that it will release its Appendix 4C quarterly cash flow and activity report for the fourth quarter of 2025 on 29 January 2026, providing an update on the company’s recent operational and financial performance. The timing of the release signals continued transparency for investors and other stakeholders as the telehealth provider executes its growth strategy in a competitive digital healthcare market, with the forthcoming report likely to inform assessments of its progress in scaling services and deepening partnerships.
The most recent analyst rating on (AU:DOC) stock is a Sell with a A$0.13 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.
Doctor Care Anywhere Group PLC has disclosed that director John Stier increased his direct holding in the company by acquiring 500,000 ordinary fully paid CHESS Depositary Interests on-market, lifting his stake from 3.5 million to 4 million securities at a total cost of AUD 73,183. The trade, placed under a standing instruction during an open trading window and approved by the board, was executed on 8 January 2026 during a closed period due to low market liquidity and holiday-related delays, with the company stating that Stier did not possess any undisclosed price-sensitive information at the time, underscoring compliance with governance and insider trading rules.
The most recent analyst rating on (AU:DOC) stock is a Sell with a A$0.13 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.